December 2016 FDA Recall Drug by Accord Healthcare, Inc.
D-0478-2017 - Failed tablet/capsule specification
This Class II drug recall was voluntarily initiated by Accord Healthcare, Inc. on December 20, 2016 for the product Drug. The FDA reported the reason for recall as failed tablet/capsule specification. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0478-2017
Failed tablet/capsule specification: missing break line on the 5mg tablet.
12-20-2016
02-22-2017
12896 bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Accord Healthcare, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
U.S. Nationwide and Puerto Rico
08-02-2017
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Lisinopril tablets, 5 mg, 1000-count bottle, Rx only, Manufactured for Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-376-17
Batch or Lot Expiration Information
Lot# T04483, T04484, Exp 2/18; T06028, Exp 4/18; T08423, Exp 5/18
